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ntegrins connect the extracellular matrix with the cell
interior, and transduce signals through interactions of
their cytoplasmic tails with cytoskeletal and signaling
proteins. Using the yeast two-hybrid system, we isolated a
 
novel splice variant (ﬁlamin-B
 
var-1
 
) of the ﬁlamentous actin
cross-linking protein, ﬁlamin-B, that interacts with the
cytoplasmic domain of the integrin 
 
 
 
1A and 
 
 
 
1D subunits.
RT-PCR analysis showed weak, but wide, expression of
ﬁlamin-B
 
var-1
 
 and a similar splice variant of ﬁlamin-A (ﬁl-
amin-A
 
var-1
 
) in human tissues. Furthermore, alternative
splice variants of ﬁlamin-B and ﬁlamin-C, from which the
 
ﬂexible hinge-1 region is deleted (
 
 
 
H1), were induced
during in vitro differentiation of C2C12 mouse myoblasts.
We show that both ﬁlamin-A
 
var-1
 
 and ﬁlamin-B
 
var-1
 
 bind
I
 
more strongly than their wild-type isoforms to different
integrin 
 
 
 
 subunits. The mere presence of the high-afﬁnity
 
binding site for 
 
 
 
1A is not sufﬁcient for targeting the ﬁl-
 
amin-B
 
var-1
 
 construct to focal contacts. Interestingly, the
simultaneous deletion of the H1 region is required for
the localization of ﬁlamin-B at the tips of actin stress ﬁbers.
When expressed in C2C12 cells, ﬁlamin-B
 
var-1
 
(
 
 
 
H1) accel-
erates their differentiation into myotubes. Furthermore,
ﬁlamin-B variants lacking the H1 region induce the formation
of thinner myotubes than those in cells containing variants
with this region. These ﬁndings suggest that speciﬁc
combinations of ﬁlamin mRNA splicing events modulate
the organization of the actin cytoskeleton and the binding
afﬁnity for integrins.
 
Introduction
 
Filamins are 
 
 
 
560-kD dimeric proteins that, based on their
conserved actin-binding domain (ABD)* and actin cross-
linking activities, belong, similar to 
 
 
 
-actinin, spectrin, and
dystrophin, to the family of actin-binding proteins. Filamins
organize filamentous actin (F-actin) into either orthogonal
networks or parallel bundles, depending on the relative ac-
tin/filamin ratio and the source of purified filamin. In hu-
mans three filamin isogenes have been identified: FLNA,
FLNB, and FLNC (Stossel et al., 2001; van der Flier and
Sonnenberg, 2001a). Filamin-A is also named ABP-280
(Gorlin et al., 1990) or filamin-1, and filamin-B is also
named ABP-278/276 (Xu et al., 1998), 
 
 
 
-filamin (Takafuta
et al., 1998), or filamin-3. Filamin-C has been cloned as
 
 
 
-filamin, ABPL (Xie et al., 1998), or filamin-2 (Thompson
et al., 2000).
The first 
 
 
 
275 NH
 
2
 
-terminal amino acids of filamin con-
tain an ABD, composed of two calponin homology do-
mains. This domain is followed by 24 repetitive, 100-resi-
due segments, interrupted by two 
 
 
 
30–amino acid flexible
loops (hinge-1 [H1] and -2), which show little homology
among the products of the filamin isogenes. The H1 loop,
between repeats 15 and 16, is lacking in some splice variants
of filamin-B and filamin-C (Xie et al., 1998; Xu et al.,
1998). It has been suggested that in the dimeric filamin mol-
ecule, the flexible H1 regions are essential for the separation
of its ABDs and thus for its ability to promote orthogonal
cross-linking of actin filaments (Gorlin et al., 1990). The
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H2 loop between repeats 23 and 24 is present in all filamin
isoforms, and the COOH-terminal repeat 24 is essential in
the tail–tail dimerization of the filamin molecule (Gorlin et
al., 1990). In addition to its ability to cross-link actin fila-
ments, filamin-A serves as a docking site for various trans-
membrane cell surface molecules such as GP-Ib
 
 
 
, Fc-
 
 
 
RI,
tissue factor, and the 
 
 
 
2 and 
 
 
 
1A integrin subunits (Ohta et
al., 1991, 1999; Sharma et al., 1995; Meyer et al., 1997; Loo
et al., 1998; Pfaff et al.,1998; Calderwood et al., 1999). Fil-
amin-B binds to GP-Ib
 
 
 
 (Takafuta et al., 1998; Xu et al.,
1998), whereas the muscle-associated filamin-C binds to
sarcoglycans (Thompson et al., 2000) and a number of mus-
cle-specific proteins (Faulkner et al., 2000; van der Ven et
al., 2000; Takada et al., 2001). Furthermore, intracellular
signal transduction proteins, such as the small GTPases
RalA, RhoA, Rac-1, Cdc42 (Ohta et al., 1999), the guani-
dine-exchange factor Trio (Bellanger et al., 2000), the tumor
necrosis factor receptor–associated factor-2 (Leonardi et al.,
2000), and the membrane-associated proteases, furin and
presenilin, bind to filamin (Liu et al., 1997; Zhang et al.,
1998). These interactions point to a scaffolding function of
filamin, rather than a distinct role as an actin filament–orga-
nizing molecule. Analyses of melanocytic cell lines deficient
in filamin-A (Cunningham et al., 1992), as well as of pa-
tients with the neuronal migration disorder periventricular
heterotopia (Fox et al., 1998; Sheen et al., 2001), indicate a
role for filamin-A in cell motility during stabilization of the
cell membrane. However, relatively little is known about the
specific roles of filamin variants in the properties of cells and
the regulation of cellular processes.
Integrins are heterodimeric adhesion receptors that pro-
vide a structural link between proteins of the extracellular
matrix (e.g., fibronectin, laminin, and collagen) and the in-
tracellular cytoskeleton (Hynes, 1992; van der Flier and
Sonnenberg, 2001b). In addition, integrins play a role in
several different signaling events (Giancotti and Ruoslahti,
1999). Although the small (20–50 amino acids) cytoplas-
mic tails of the integrin 
 
 
 
 and 
 
 
 
 subunits have no intrinsic
catalytic domains or obvious protein–protein interaction
domains, studies combining biochemical and genetic ap-
proaches, have led to the identification of a range of cy-
toskeletal, adaptor, and signaling molecules, which interact
with the integrin cytoplasmic tails and are therefore impli-
cated in integrin function (Liu et al., 2000; van der Flier
and Sonnenberg, 2001b). Cytoskeletal proteins, such as
the actin cross-linking proteins talin, 
 
 
 
-actinin, and fil-
amin-A (Critchley, 2000), interact with integrin 
 
 
 
 sub-
units. These molecules have been implicated in the linking
of actin stress fibers to the cell membrane at specialized
structures, known as focal adhesions or focal contacts,
which are formed at cell–substrate contact sites. Binding to
 
 
 
 subunits of this class of proteins was originally shown in
biochemical experiments and was recently confirmed in
yeast two-hybrid assays (Loo et al., 1998). Another cate-
gory of proteins that interact with integrins are signaling
molecules, including the ARF-GEF protein, cytohesin-1,
the WD-repeat proteins Rack1 and WAIT-1, ICAP-1, and
integrin-linked kinase (Hannigan et al., 1996; Kolanus et
al., 1996; Chang et al., 1997; Liliental and Chang, 1998;
Rietzler et al., 1998).
 
This study originated with the desire to identify cytoplas-
mic proteins that bind to the integrin 
 
 
 
1D subunit, specifi-
cally in cardiac and skeletal muscle. Using the yeast two-
hybrid technique, we isolated a new splice variant of filamin-B.
Characterization of the interactions in yeast two-hybrid
analyses and biochemical assays indicated that this filamin
variant has a high binding activity and a broad specificity for
integrin 
 
 
 
 subunits. Subsequent analysis of filamin mRNA
splicing during in vitro myogenesis revealed that the H1 re-
gion of filamin-B and filamin-C is removed during the dif-
ferentiation of myoblasts. Transfection studies with different
filamin-B variants tagged with green fluorescent protein
(GFP) revealed that the interaction with integrins and the
cellular localization of the various filamin variants is differ-
ent, and they affect myotube morphology and the pace of
in vitro myogenesis of C2C12 cells in a variant-specific
manner.
 
Results
 
A novel filamin-B splice variant interacts with the 
 
 
 
1D 
integrin subunit in yeast
 
To identify proteins that interact with the cytoplasmic do-
main of 
 
 
 
1D, specific for cardiac and skeletal muscle, we
screened a human skeletal muscle cDNA library for interact-
ing clones, using the 
 
 
 
1D cytoplasmic domain as bait in a
yeast two-hybrid screen. Approximately 6 
 
 
 
 10
 
6
 
 clones were
screened. From 67 positive clones, two identical clones en-
coding the 5 COOH-terminal repeats of filamin-B (amino
acids 2027–2602) were isolated. Strikingly, in both filamin-B
clones, 41 amino acids were deleted from the region be-
tween filamin repeats 19 and 20 (residues 2082–2122). This
filamin variant was named filamin-B
 
var-1
 
. In a yeast two-
hybrid screen for clones interacting with 
 
 
 
1A, using a hu-
man keratinocyte cDNA library (29 
 
 
 
 10
 
6
 
 clones), we iso-
lated, from 16 positive clones, 4 identical filamin-B
 
var-1
 
clones. The other isolated clones encoded either false posi-
tives or will be described elsewhere. Additionally, a filamin-
B
 
var-1
 
 clone encoding EST was published under GenBank/
EMBL/DDBJ accession no. W40525 (pancreatic islets).
These results show that filamin-B
 
var-1
 
 binds to the cytoplas-
mic domains of both 
 
 
 
1A and 
 
 
 
1D, and the expression of
filamin-B
 
var-1
 
 is not restricted to skeletal muscle.
 
Expression and genomic determination of novel 
filamin-B splice variants
 
To explore the expression pattern of the transcript for fil-
amin-B
 
var-1
 
, cDNAs of multiple human tissues were analyzed
in a PCR reaction, using primers that flank repeats 19 and
20 of filamin-B. Fig. 1 A shows that the cDNA encoding the
previously reported filamin-B wild-type sequence was ampli-
fied from all tissues tested (683-bp product). In addition, a
smaller PCR product of 560 bp, corresponding to the fil-
amin-B
 
var-1
 
 specific part, was detectable in heart, lung, and
skeletal muscle. Nested PCR analysis revealed a weak expres-
sion of filamin-B
 
var-1
 
 in all tissues tested (unpublished data).
A similar splice variant lacking the corresponding region
(amino acids 2127–2167) in human filamin-A, filamin-A
 
var-1
 
,
was also detected by (nested) PCR analysis (unpublished 
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data). Two additional filamin-B–specific PCR products of
830 (filamin-B
 
var-2
 
) and 753 bp (filamin-B
 
var-3
 
) were detected
in cardiac tissue (Fig. 1 A). Cloning and sequencing of these
PCR fragments revealed that they represent two partially
overlapping cardiac filamin-B cDNAs (Fig. 1 B). Intrigu-
ingly, in filamin-B
 
var-2
 
, the insertion of a 147-bp sequence
results in a truncated protein with a unique COOH-termi-
nal sequence of 24 amino acids. The insertion in filamin-
B
 
var-3
 
 of only the first 70 of the 147 bp inserted in filamin-
B
 
var-2
 
 leads to a frameshift, and as a result, four more amino
acids are encoded COOH-terminally in this protein. Hence,
both cardiac-specific filamin-B transcripts encode truncated
filamin-B proteins that lack the four COOH-terminal re-
peats, including the 24th dimerization domain.
Genomic PCR mapping with primers designed from ex-
ons 39 and 41, encoding the filamin repeats 19 and 20 (Fig.
1, C and D), revealed that the stretch of 41 amino acids, de-
leted in filamin-B
 
var-1
 
, is encoded by a single exon of 123 bp.
This exon is preceded by a 102-bp intron and followed by
an intron of 
 
 
 
2.5 kb. Furthermore, we found that the
cDNA sequence of filamin-B
 
var-2
 
, specific for heart, is en-
coded by a 147-bp exon, exon 40B/C. Alternative RNA
splicing at the internal splice site, located in exon 40B/C,
produces the filamin-B
 
var-3
 
 transcript.
 
Filamin isoforms and their variants determine 
specificity for association with 
 
 
 
 subunits
 
We next tested the interaction of the COOH-terminal do-
main, i.e., repeats 19–24 of filamin-B and filamin-B
 
var-1
 
 with
different 
 
 
 
 subunits, using the yeast two-hybrid system. In
addition, we tested the homologous regions of filamin-A and
filamin-A
 
var-1
 
. The results (Fig. 2 A) show that the COOH-
terminal domain of wild-type filamin-B(19–24), containing
repeats 19–24, interacts only with 
 
 
 
1A. In contrast, an
equivalent construct encoding filamin-B
 
var-1
 
(19–24), which
lacks amino acids 2082–2122 that span repeats 19 and 20,
and an NH
 
2
 
-terminal deletion mutant of filamin-B, trun-
cated at amino acid 2123 (filamin-B, 20*–24), bind not
only to 
 
 
 
1A but also to the 
 
 
 
1D, 
 
 
 
3, and 
 
 
 
6 subunits. Sim-
ilar results were obtained with proteins from the original iso-
Figure 1. Identification of three human filamin-B variants and analysis of the genomic organization of the FLN-B gene. (A) Tissue expression 
of filamin-B variants. PCR was performed on a human multiple tissue cDNA panel, using primers BV1 and BV2 designed to amplify repeats 
19 and 20 of filamin-B. The 683-bp band, representing wild-type filamin-B, is present in all samples tested. The 560-bp product marked by 
one asterisk represents filamin-Bvar-1. The cardiac splice variants (filamin-Bvar-2, 830 bp, and filamin-Bvar-3, 753 bp) are indicated by two asterisks. 
(B) The partial cDNA sequences and deduced amino acid sequence of the human filamin-B variants. The translation of the two cardiac 
variants (Bvar-2 and Bvar-3), as well as wild-type and filamin-Bvar-1 is indicated in single letter code. Dots indicate the presence of nucleotides, 
whereas slashes indicate deletion of the corresponding nucleotides. The putative cAMP-kinase sequence is underlined. The nucleotide 
sequence data are available from GenBank/EMBL/DDBJ under accession no. AF353666. (C) Schematic diagram representing the genomic 
organization of the region of FLN-B encoding the repeats 19 and 20 and the composition of the cDNA splice variants. Arrows indicate positions 
of primers used for cloning. (D) Boundaries at the exon–intron junctions of the FLN-B gene segment. Sizes of exons and introns are indicated 
as are the consensus splice donor and acceptor sequences; GT/AG of each exon–intron border are underlined. Exons are numbered according to 
Chakarova et al. (2000). (Footnotes a and b) Nucleotides are numbered according to GenBank/EMBL/DDBJ accession nos. NM_001457 and 
AF353667 (Fig. 1 D), respectively. 
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lated filamin-B
 
var-1
 
 clones that contain amino acids 2027–
2602 (unpublished data). Quantitative 
 
 
 
-galactosidase ac-
tivity assays indicated that filamin-B
 
var-1
 
(19–24) bound two
to three times more strongly to 
 
 
 
1A than did wild-type fil-
amin-B(19–24) (Fig. 2 B). The binding of filamin-B
 
var-1
 
(19–
24) to 
 
 
 
3 was weaker and comparable to that of wild-type
filamin-B(19–24) to 
 
 
 
1A, and that of filamin-B
 
var-1
 
(19–24)
to 
 
 
 
1D was of intermediate strength.
In contrast to filamin-B(19–24), the corresponding fil-
amin-A(19–24) construct did not bind to 
 
 
 
1A or any other
 
 
 
 subunit. However, filamin-A
 
var-1
 
(19–24) and the shorter
filamin-A(20*–24) construct (amino acids 2168–2647) in-
teracted strongly with 
 
 
 
1A and weakly with 
 
 
 
3 and 
 
 
 
6, but
neither of them interacted with 
 
 
 
1D. None of the afore-
mentioned filamin constructs interacted with the 
 
 
 
2 cyto-
plasmic domain (unpublished data). Taken together, these
data show that the affinity of filamin-B for 
 
 
 
1A is strongly
increased when the stretch of 41 amino acids is deleted from
it. Similarly, the removal of the same region from filamin-A
induces binding to 
 
 
 
1A. Furthermore, both variants become
capable of binding to other integrin 
 
 
 
 subunits.
Analysis of a series of filamin-B constructs truncated at the
NH
 
2
 
 or COOH terminus indicates that repeat 21 is neces-
sary, but not sufficient, for interaction with 
 
 
 
1A (Fig. 2 A).
It is possible that the presence of repeat 24 facilitates the
dimerization of filamin, and thus of repeat 21, thereby
greatly increasing the strength of the binding to 
 
 
 
1A. The
interaction of filamin-B
 
var-1
 
 with 
 
 
 
3 and 
 
 
 
6 was abolished
by the deletion of repeats 23–24, whereas it did not affect
binding to 
 
 
 
1A or 
 
 
 
1D. Interactions of both 
 
 
 
1A and 
 
 
 
1D
with filamin-B
 
var-1
 
(19 and 20) could still be demonstrated,
although the binding appeared to be weaker than that of a
construct containing repeat 21, filamin-B
 
var-1
 
(19–21). These
data suggest that deletion of the 41–amino acid region in fil-
amin-B leads to either the removal of inhibitory sequences
in repeat 19 or to the introduction of a new binding site for
 
 
 
1A and 
 
 
 
1D in the remaining part of repeat 20 (amino ac-
ids 1995–2185). The presence of repeat 21 increases bind-
ing activity, which is consistent with the data showing that
this repeat is necessary for efficient binding of filamin-B to
 
 
 
1A and contributes to the binding activity of filamin-B
 
var-1
 
(19–21) to 
 
 
 
1 integrins. As may be the case for the binding
Figure 2. Characterization of the interaction of filamin isoforms and variants with the cytoplasmic domains of different integrin   subunits in 
yeast. (A) Cotransformation of yeast host strain PJ69–4A with the listed combinations of   integrin cytoplasmic domains (pAS2.1) and filamin-A 
and filamin-B deletion constructs (pACT). The NH2- and COOH-terminal positions of the different filamin constructs are indicated. Numbers 
in parentheses refer to the repeats present in the different constructs. The partially truncated repeat 20 is indicated by an asterisk. Interactions 
were scored ( ) when the plating efficiencies on selective SC-LTHA plates were greater than 80% of those on nonselective SC-LT plates at
5 d of growth, ( ) when they were greater than 80% at 10 d of growth, and ( ) when no colonies were detected after 10 d of growth. (B) 
 -Galactosidase activity of the indicated cotransformants was measured by a liquid culture assay with O-nitrophenyl B-D-galactopyranoside as 
substrate. Controls were used: negative interaction control, empty vectors pAS/pACT; positive interaction control, p53/pSV-40 large T and the 
complete Gal4 domain pCL1/pAS (171   6  -galactosidase units; unpublished data). Data are shown as mean   SD (n   3). 
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of filamin-B to 
 
 
 
1A, binding of filamin-B
 
var-1
 
 to 
 
 
 
3 and 
 
 
 
6
probably requires dimerization mediated by repeat 24.
 
Biochemical interaction of filamin variants 
with integrins
 
To confirm the interactions between the different filamin
splice variants and the 
 
 
 
1A and 
 
 
 
1D subunits observed in
yeast, we expressed the regions containing repeats 19–24 of
filamin-A
 
var-1
 
 or filamin-B
 
var-1
 
, or the corresponding regions
of wild-type filamin-A(19–24) or filamin-B(19–24), in
COS-7 cells. The proteins were tagged at their NH
 
2
 
 termi-
nus with hemagglutinin A (HA) and expression of equiva-
lent amounts of proteins in COS-7 cells was confirmed by
immunoblotting with anti-HA antibody (Fig. 3 A). Binding
of the filamin constructs to
 
  
 
1A and  1D was tested in a
pull-down assay using glutathione-S-transferase (GST) fu-
sion proteins containing the cytoplasmic domains of these
integrin subunits, immobilized on glutathione-Sepharose
beads (Fig. 3 B). As shown in Fig. 3 C, GST– 1A bound to
filamin-Avar-1(19–24) and filamin-Bvar-1(19–24), but not to
the corresponding fragments of the wild-type filamin iso-
forms (filamin-A, 19–24, and filamin-B, 19–24). Binding of
GST– 1D to the different filamin-A and filamin-B con-
structs was either undetectable or very weak. The interaction
between  1A and filamin-B(19–24) detected in yeast could
not be confirmed in the pull-down assay, probably because
it is too weak. Interestingly, we found that a truncated fil-
amin-B construct that lacks the first 14 amino acids of re-
peat 19 (filamin-B, 2009–2602) could be efficiently precipi-
tated with GST– 1A (unpublished data). Thus, it appears
that not only the deletion of COOH-terminal residues of re-
peat 19, as in the variant-1 protein, but also the deletion of
NH2-terminal residues of repeat 19 results in stronger bind-
ing of filamin-B to  1A. Together, these data suggest that
repeat 19 contains an inhibitory element for binding of fil-
amin-B to   subunits.
Identification of the binding sites for filamins on  1A 
and  1D
Next, we determined the binding sites for filamin-B and the
splice variants of filamin-A and filamin-B on the cytoplas-
mic domains of the  1A and  1D subunits (Fig. 4). Swap-
ping the COOH-terminal residues of  1A and  1D in
 1A/D
796 (EGK to GRKAGL) and  1A/D
792 (NPKYEGK
to NPNYGRAGL) had no effect on their binding to fil-
amin-B(19–24), filamin-Bvar-1(19–24), and filamin-A(20–
24). A swap involving the membrane-proximal region of
 1D, where the G
778 and A
786 residues in  1A are replaced
by the corresponding Q
778 and P
786 residues from  1D,
leads to complete abolition of the interaction with filamin-
B(19–24) and filamin-A(20*–24). Binding of filamin-Bvar-1
(19–24) could still be detected, although it was weaker.
These results indicate that the specificity of the binding of
filamin-B and filamin-Avar-1 with  1A depends on the two
residues, G
778 and A
786, that have been substituted in  1D
by Q
778 and P
786. Although a role for Q
778 cannot be ex-
cluded, we propose that P
786, by its ability to create a bend
or a rigid kink in polypeptide chains, changes the conforma-
tion of the  1D cytoplasmic domain in such a way that it
can no longer bind to filamin-B or filamin-Avar-1.
Analysis of deletions of the cytoplasmic domain of  1A
shows that for binding to filamin-B, almost the complete cy-
toplasmic domain of  1A is required. Only the last 10
COOH-terminal amino acids of  1A can be deleted with-
out causing a loss of interaction. The binding site for fil-
amin-Bvar-1 on  1A comprises both the NPXY motifs and
the intervening sequence, whereas on  1D additional mem-
brane proximal sequences are needed. Similarly, the minimal
binding site for filamin-A(20*–24) on  1A comprises the
two NPXY motifs and the intervening sequence, which re-
sembles the binding site for filamin-Bvar-1. Thus, it appears
that the binding site on  1A for the low-affinity interaction
with filamin-B is distinct from the one mediating high-affin-
ity binding to filamin-Avar-1 and filamin-Bvar-1. The sequence
requirements for the binding of  1D to filamin-Bvar-1 resem-
Figure 3. Binding of filamin isoforms and variants to GST– 1A 
and – 1D fusion proteins. (A) Detection of the expressed products 
from HA-tagged filamin-B cDNA constructs (filamin repeats 19–24) 
in lysates of COS-7 cells, transiently transfected with the indicated 
constructs. The upper band represents nonspecific reactivity of the 
antibody with an endogenous protein. (B) Expression of recombinant 
GST– 1A and – 1D fusion proteins. The GST fusion proteins 
containing the cytoplasmic domains of  1A and  1D were purified 
on glutathione-Sepharose 4B beads and analyzed by immunoblotting 
with antibodies against GST,  1A, and  1D subunits. (C) Pull-down 
assay with GST or GST– 1A and – 1D fusion proteins, immobilized 
on glutathione beads (A) containing HA-tagged fusion proteins as 
indicated. (Top) Immunoblot detection of bound filamin-Avar-1 and 
filamin-Bvar-1 to GST– 1A and very weak binding to GST– 1D. No 
binding was detected to filamin-A and filamin-B. (Bottom) 
Coomassie blue–stained polyvinylidene difluoride membrane 
showing the amount of GST fusion proteins used for each pull-
down assay.366 The Journal of Cell Biology | Volume 156, Number 2, 2002
ble those for the low affinity interaction of  1A to filamin-B
(Fig. 2).
Alternative splicing of filamins during in
vitro myogenesis
During differentiation of mouse C2C12 myoblasts into myo-
tubes, the expression of  1D is induced, whereas that of
 1A is downregulated (Belkin et al., 1997; van der Flier et
al., 1997). We investigated whether this switch is paralleled
by changes in the expression of filamin isoforms and/or their
variants. Total RNA was isolated at different time points of
myogenic differentiation, and the expression of filamin iso-
forms was analyzed by RT-PCR using appropriate primers.
We studied the splicing of the region encoding the 41 amino
acids in filamin-A and filamin-B, as well that of the H1 re-
gion of filamin-A, filamin-B, and filamin-C (Fig. 5 A). The
latter were included because variants of human filamin-B
and filamin-C, lacking the H1 region, have been described
previously (Xie et al., 1998; Xu et al., 1998). Fig. 5, B–D,
shows that C2C12 myoblasts express all three murine fil-
Figure 4. Characterization of the 
interaction between mutants of the 
 1A and  1D cytoplasmic domain 
with filamin-A and filamin-B splice 
variants by yeast two-hybrid analysis. 
Cotransformation of yeast host strain 
PJ69–4A with the listed combinations 
of   integrin cytoplasmic domains 
(in pAS) and filamin (in pACT). Interaction 
was scored as in Fig. 2. The numbers 
represent the amino acid positions in 
 1A and  1D. The conserved NPXY 
motifs are underlined and the amino 
acids in  1D that were swapped in the different chimeras are indicated by shading. The common membrane proximal region, which is 
shared between  1A and  1D, is boxed.
Figure 5. Expression of filamin isoforms and variants during in 
vitro myogenesis. (A) Schematic representation of the organization 
of the filamin domains and the regions analyzed by RT-PCR. (B) 
RT-PCR analysis of alternative splicing of the H1 region of filamin-A, 
filamin-B, and filamin-C in mouse C2C12 myoblasts and murine 
tissues, as indicated. Splicing is analyzed at the indicated time 
points after induction of differentiation. The H1 region of filamin-A 
is not spliced, whereas in filamin-B and filamin-C the H1 region is 
removed during myogenesis. Filamin-B(H1s) is detected in C2C12 
cells and adult tissues. The switching from the  1A to the  1D variant 
during C2C12 differentiation is shown. (C) Immunoblot of the protein expression levels of filamin-B  1D, and MHC during myogenesis. 
Filamin-B expression decreases, while the myogenic differentiation markers  1D and MHC are both induced. (D) Amino acid alignment of 
the human and murine H1 and variable-1 region. The partial murine filamin sequences are available from GenBank/EMBL/DDBJ under 
accession nos. AF353668–353670.Integrin binding to filamin isoforms and variants | van der Flier et al. 367
amin isoforms. In addition, whereas the H1 region is present
in filamin-A throughout differentiation, this region is absent
from the filamin-B and filamin-C isoforms. This deletion
appears to precede the switch from  1A to  1D that occurs
during myogenic differentiation. Interestingly, we detected
in C2C12 cells and among several murine and human
cDNAs (unpublished data) a third filamin-B transcript that
encodes a variant with a shorter H1 (H1s) region (Fig. 5 D).
This transcript arises as a result of the usage of intrinsic
splice-donor and acceptor sites that are present in the
murine and human filamin-B genes (position 5280 and
5312, respectively; GenBank/EMBL/DDBJ accession no.
NM_001457). We did not detect the filamin-Avar-1 and fil-
amin-Bvar-1 transcripts.
The expression of filamin-B proteins in C2C12 cells was
assessed by immunoblotting with an antibody specific for
the H1 region of filamin-B (Fig. 5 C). In agreement with
the PCR data, the level of filamin-B protein containing the
H1 region decreased during the differentiation of C2C12
cells. In contrast, the expression of  1D and sarcomeric my-
osin heavy chain (MHC) was induced in differentiating
C2C12 cells.
GFP COOH-terminal tags do not interfere 
with filamin dimerization
Before initiating studies to define the cellular localization of the
different splice variants of filamin-B, we examined whether the
addition of GFP at the COOH terminus of filamin influences
the ability of this protein to form dimers. To this end, a fil-
amin-B(19–24) construct with GFP at the COOH-terminal
end, and a control construct, tagged with HA at the NH2-ter-
minal end, were transiently expressed in CHO cells. After 2 d,
cell lysates and intact cells were treated with the chemical cross-
linking reagent dithiobis-succinimidyl propionate (DSP) at
two concentrations. As shown in Fig. 6, the addition of in-
creasing amounts of cross-linker led to a shift from monomeric
to dimeric tagged filamins, as visualized by immunoblotting
with antibodies against HA or GFP. The similar dimerization
capacity of HA- and GFP-tagged filamin-B(19–24) indicates
that the GFP tag had no effect on dimerization. The same sam-
ples under reducing conditions, which disrupt the disulfide
bond, only contained filamin monomers. Specificity of the
cross-linking reaction was checked using the NH2-terminal
HA-tagged filamin-Bvar-1(19–23) construct, which did not
form dimers due to truncation of the COOH-terminal repeat
24, which is required for dimerization.
Subcellular distribution of full-length filamin-B variants 
and their interaction with  1 subunits
After excluding potential disadvantageous effects of the GFP
tag on the dimerization of filamin, we generated full-length
cDNAs encoding four different filamin-B splice variants and
tagged them with GFP (Fig. 7 A). These include the previ-
ously reported filamin-B and filamin-B lacking H1 (filamin-
B[ H1]), as well as the novel identified filamin-B lacking
the 41 residues between repeats 19 and 20 (filamin-Bvar-1),
and filamin-Bvar-1 without H1 (filamin-Bvar-1[ H1]). As
shown in Fig. 7 B, the latter two filamin-B variants are ex-
pressed in a variety of tissues and cell types, including heart,
lung, testis, spleen, thymus, and leukocytes. Several cell types
were retrovirally transduced, and after fluorescence-activated
cell sorting for filamin-GFP–expressing cells, the stable ex-
pression of the different filamin fusion proteins was verified
by immunoblotting. In all cell lines, full-length GFP-tagged
filamin-B variants migrating at  300 kD could be detected
(shown for C2C12, Fig. 7 C). Filamin-B expression levels
were consistently lower than those of the other variants,
which were comparable to each other. Occasionally, smaller
protein degradation products were detected, which varied in
size and quantity, depending on the transduced cell line and
the filamin variant (Fig. 7 C). GST pull-down assays con-
firmed that deletion of the variant-1 region from full-length
filamin-B increases binding to  1 integrins (Fig. 7 D). Only
the two filamin-B constructs, filamin-Bvar-1 and filamin-Bvar-1
( H1), in which the variant-1 region had been deleted, but
not filamin-B or filamin-B( H1), were precipitated by
GST– 1A (Fig. 7 D). Binding of filamin-Bvar-1 and filamin-
Bvar-1( H1) to  1D again proved to be weak and could only
be demonstrated after long exposures of the film. None of
the filamin-B constructs interacted with GST.
The subcellular distribution of the different GFP-tagged
filamin-B variants was examined in GD25- 1A mouse fibro-
blasts stably expressing these proteins. The localization of
GFP-tagged filamin-B (Fig. 8, C and D) was identical to that
of endogenous filamin-B, as revealed by immunostaining us-
ing an antibody against the H1 region of filamin-B (Fig. 8, A
Figure 6. The GFP tag on the COOH-terminal part of filamin-B 
does not interfere with dimerization in vivo. CHO cells were 
transfected with either the NH2-terminal HA- or the COOH-terminal 
GFP-tagged FLN-B(19–24) or with the NH2-terminal HA-tagged 
FLN-Bvar-1(19–23) construct lacking the last repeat. 2 d after 
transfection, filamin dimers in either cell lysates (lysate) or intact 
cells (cells) were stabilized by chemical cross-linking at two 
different concentrations of DSP for 1 h, and dimerization of the 
epitope-tagged filamins was analyzed by immunoblotting under 
nonreducing conditions (NR) using anti-HA and anti-GFP antibodies. 
The specificity of the cross-linkage was checked by including 
NH2-terminal HA-tagged FLN-Bvar-1(19–23), in which the truncation 
of COOH-terminal repeat 24 abolished dimerization. In addition, 
cross-linked samples were separated under reducing (R), DSP 
disrupting conditions resulting in the presence of filamin-B monomers. 
Closed arrowheads indicate HA-tagged products, and open arrow-
heads indicate GFP-tagged fusion proteins. A single arrow indicates 
a filamin monomer, and an arrow doublet indicates dimers.368 The Journal of Cell Biology | Volume 156, Number 2, 2002
and B). Thus, the GFP tag did not interfere with the normal
localization of filamin-B. Filamin-B was localized at actin
stress fibers but was not appreciably concentrated in focal
contacts. The distribution of filamin-B( H1) and filamin-
Bvar-1 variants was similar to that of filamin-B (Fig. 8, E and
F). Interestingly, filamin-Bvar-1( H1) was associated with a
proportion of the peripheral focal contacts positive for vincu-
lin (Fig. 8, G–O, and Fig. 9 E). There was also GFP fluores-
cence in the nucleus in many of these cells, the significance of
which is unknown. As anticipated, the filamin-Bvar-1( H1)
variant did not react with anti–filamin-B H1 antibody. How-
ever, its presence in focal contacts was revealed by GFP fluo-
rescence, whereas endogenous filamin-B, which does react
with this antibody, was found associated with actin stress fi-
bers (Fig. 8, M–O). Neither endogenous filamin-B (Fig. 8 B)
nor any of the filamin-B variants (unpublished data) were en-
riched in lamellipodia. The expression of filamin-Bvar-1( H1)
in focal contacts did not have an apparent effect on the com-
position and localization of these structures. They were con-
fined at the end of actin stress fibers (Fig. 8, J–L, and Fig. 9 F)
and in addition to vinculin, they contained talin, phospho-
tyrosine, and paxillin (Fig. 9, A, B, and D). We did not detect
 -actinin in focal contacts (Fig. 9 C). Lastly, in GD25- 1D
cells expressing filamin-Bvar-1( H1) there was also a promi-
nent staining of some focal contacts (unpublished data).
We conclude that the localization of filamin-Bvar-1( H1)
in focal contacts requires, in addition to the characterized
variant-1 high-affinity binding site for  1 integrins, a func-
tion that is induced by the loss of the H1 region.
Filamin-B variants affect myoblast 
differentiation in vitro
The functional significance of the developmentally regulated
splicing of the H1 region in filamin-B, as well as the deletion
Figure 7. Expression of filamin-B variants in human tissues, and characterization of the binding of full-length filamin-B variants to integrin 
cytoplasmic domains. (A) Schematic presentation of COOH-terminal GFP-tagged filamin-B variant constructs. The internal deletions of 
filamin-B are indicated by a single line. (B) Detection by PCR amplification of filamin-Bvar-1 and filamin-Bvar-1( H1) transcripts. PCR was 
performed on cDNAs from different human tissues, using primers BV12 and BV13 (A) designed to specifically amplify filamin-Bvar-1(  H1) 
cDNAs. cDNAs encoding filamin-B variants with and without the var-1 region were used as positive and negative controls, respectively. As 
a further negative control, cDNA for filamin-A was used. A PCR product for filamin-Bvar-1 was amplified from most tissues. Heart, spleen, and 
thymus contained transcripts for filamin-Bvar-1( H1). A third PCR product (indicated by an asterisk) that migrated slightly faster than the 
filamin-Bvar-1 variant and is present in heart, kidney, liver, lung, and colon, corresponds to filamin-Bvar-1(H1s). The authenticity of the PCR 
products has been confirmed by sequencing. (C) Expression of GFP-tagged filamin-B variants in C2C12 myoblasts. Stably transduced C2C12 
cells were obtained as described in the Materials and methods. Equal amounts of total cells lysed in boiling sample buffer were analyzed by 
immunoblotting. Filamin-B–GFP was detected by mouse anti-GFP antibody. The upper bands represent the full-length filamin–GFP fusion 
proteins whereas some fainter lower bands represent COOH-terminal proteolytic products. (D) Pull-down assay of full-length filamin-B 
variants with GST or GST– 1A and – 1D fusion proteins immobilized on glutathione beads containing GFP-tagged fusion proteins as 
indicated. Immunoblotting showed binding of filamin-Bvar-1 and filamin-Bvar-1( H1) to GST– 1A, weak binding to GST– 1D, whereas filamin-B 
and filamin-B( H1) did not bind.Integrin binding to filamin isoforms and variants | van der Flier et al. 369
of the 41–amino acid region, was explored by analyzing the
effects of ectopic expression of the four different filamin-B
splice variants on myogenesis of C2C12 cells. Myogenic dif-
ferentiation was induced by switching the culture to a me-
dium containing 2% horse serum (differentiation medium).
Interestingly, C2C12 cells expressing filamin-Bvar-1( H1)
fused into myotubes within 2 to 3 d after the medium
switch, which is 1–2 d earlier than the fusing of cells from
the other transduced cell lines (Fig. 10 A). Furthermore, the
myotubes formed by the cells expressing the filamin-B vari-
ants lacking the H1 region (filamin-B[ H1] and filamin-
Bvar-1[ H1]) were thinner than those formed by the other
transduced cell lines or GFP control cells. This difference in
morphology was more obvious when the myotubes were
stained for MHC (Figs. 11 and 12).
In the differentiating myotubes, filamin-B, filamin-Bvar-1,
and filamin-B( H1) were localized diffusely throughout the
cytoplasm, with regions of enrichment at the longitudinal
actin stress fibers (Fig. 11, B and E). In contrast, the local-
ization of filamin-Bvar-1( H1) was typically polarized and
dotted at the periphery of tubes (Fig. 11, C and F). GFP
alone was mainly localized in the nucleus (Fig. 11, A and
D). Occasionally, depending on the culture conditions, in
well-differentiated tubes with clear sarcomeric organization,
filamin-B was localized at the Z-lines, as shown by costain-
ing for sarcomeric  -actinin, and at intermediate M-bands
(Fig. 12, E and F).
Immunoblot analysis of MHC demonstrated that the
morphological differentiation is accompanied by bio-
chemical changes. The induction of MHC in the filamin-
Bvar-1( H1)–expressing C2C12 cells was faster than in the
other cells, where the induction was similar to that in
GFP control cells (Fig. 10 B). Taken together, these re-
sults show that expression of the filamin-double variant,
filamin-Bvar-1( H1), accelerates muscle differentiation in
vitro.
Figure 8. Expression and localization of 
filamin-B variants in GD25– 1A mouse fibroblasts. 
GD25– 1A cells (A and B) and GD25– 1A cells 
stably expressing GFP-tagged filamin-B (C and D), 
filamin-Bvar-1 (E), or filamin-Bvar-1( H1) (F–O), were 
analyzed for endogenous filamin-B (A, B, and M) 
and vinculin (A, D–G, and I) expression using 
indirect immunofluorescence microscopy, staining 
of F-actin (B, C, J, and L) with Alexa
®568-phalloidin, 
and GFP fluorescence (C–F, H, I, K, and N). 
Filamin-B and the variants filamin-Bvar-1 and 
filamin-B( H1) are associated with actin stress 
fibers: they did not accumulate in focal contacts. In 
contrast, filamin-Bvar-1( H1) is concentrated in 
focal contacts (G–I) at the end of actin stress fibers 
(J–L, N, and O). Note that the fluorescence pattern 
of filamin-B–GFP is similar to that of endogenous 
filamin-B detected with a polyclonal antibody 
specific for the H1 region of this filamin isoform. 
This antibody does not react with filamin-B( H1) 
and therefore in cells that express this variant, it 
does not react with focal contacts. Filamin-B is 
not present in membrane ruffles (B, arrow). 
Bars, 10  m.370 The Journal of Cell Biology | Volume 156, Number 2, 2002
Discussion
In the present study, we have identified novel distinct splice
variants produced by the filamin-A and filamin-B genes, and
report on functional differences between filamin isoforms
and their variants. We found that the deletion of 41 amino
acids encoded by exon 40 from filamin-A and filamin-B,
which generates the variants filamin-Avar-1 and filamin-Bvar-1,
greatly influences their interaction with integrin   subunits.
The role of two additional heart-specific filamin-B variants,
filamin-Bvar-2 and filamin-Bvar-3, which lack the last four re-
peated sequences of filamin-B, including the putative dimer-
ization domain, remains elusive. COOH-terminal truncated
filamin variants of Drosophila filamin-240 have also been re-
ported (Li et al., 1999b; Sokol and Cooley, 1999; Guo et al.,
2000). Furthermore, the recent identification of truncated
variants of several other high molecular weight proteins that
cross-link actin: i.e., dystropin/utrophin, dystonin, and plec-
tin (Fuchs and Yang, 1999; Blake and Kroger, 2000; Zuellig
et al., 2000), raises the interesting possibility that these vari-
ants play an unprecedented role in the regulation of actin
dynamics and the modification of F-actin organization.
Finally, analysis of the splicing of mRNAs for filamins
during in vitro myogenesis of C2C12 cells revealed that the
H1 region of filamin-B and filamin-C is removed during
myotube formation. The biological consequences of these
modifications are discussed below.
Specific interactions of filamin variants
The novel filamin-B variant, filamin-Bvar-1, is the fourth re-
ported  1D-binding protein identified in a yeast two-hybrid
scree; the other three are MIBP, melusin, and skelemin
(Reddy et al., 1998; Brancaccio et al., 1999; Li et al., 1999a).
The yeast two-hybrid interaction assays indicated that fil-
amin-A does not bind to any integrin   subunit, whereas fil-
amin-B only interacts with  1A. On the contrary, the splice
Figure 9. Localization of filamin-Bvar-1( H1) in focal contacts. 
Confocal microscopy of GD25- 1A cells showing the green fluores-
cence of filamin-Bvar-1( H1) compared with red talin (A), phospho-
tyrosine (B),  -actinin (C), paxillin (D), vinculin (E), and F-actin (F). 
Insets in C and D are at higher magnifications. Filamin-Bvar-1( H1) is 
found at the end of actin stress fibers and is colocalized (yellow) 
with talin, phosphotyrosine, paxillin, and vinculin in focal contacts. 
Bars: (A–D) 10  m; (E and F) 5  m.
Figure 10. Effects of the ectopic 
expression of filamin-B variants on 
myogenesis. C2C12 myoblasts stably 
expressing GFP and GFP fusions of the 
indicated filamin-B variants were grown 
to confluence and then switched to 
differentiation medium. (A) The phase 
contrast micrographs show the morpho-
logical appearance of the cells in culture, 
4 d after the switch to differentiation 
medium. (B) Western blot analysis of the 
expression of sarcomeric MHC in 
differentiating C2C12 cells. Cell lysates 
were prepared, separated by SDS-PAGE 
(5%), and subjected to immunoblot-
ting with antibodies against sarco-
meric MHC.Integrin binding to filamin isoforms and variants | van der Flier et al. 371
variants filamin-Avar-1 and filamin-Bvar-1 bind strongly to  1A
and weakly to  3 and  6. Additionally, a moderate binding
of filamin-Bvar-1 to  1D was observed. These results provide
evidence that isoforms and variants of filamins specifically
bind to different integrin   subunits, which render the inter-
pretation of biochemical studies with filamins more compli-
cated. Furthermore, subcellular localization and morphologi-
cal and myogenic effects were found to be determined by the
type of the expressed filamin variant.
Previously, it has been shown by coimmunoprecipitation
and pull-down assays that various integrin   subunits have
different capacities to bind cytoskeletal proteins. The results
Figure 11. Localization of GFP or 
GFP fusions of filamin-B or filamin-
Bvar-1( H1) in undifferentiated and dif-
ferentiated C2C12 cells. (A–C) Confocal 
microscopy of undifferentiated C2C12 
myoblasts showing the green fluorescence 
of GFP and two GFP fusion proteins 
(filamin-B and filamin-Bvar-1[ H1]) 
compared with red F-actin. (D–I) Triple 
stainings of differentiated myotubes. 
(D–F) Localization of GFP and GFP 
fusions (green). (G–I) Same field showing 
the distribution of sarcomeric MHC (red) 
and nuclei (blue).
Figure 12. Effects of filamin-B variants 
on myogenesis. Confocal microscopy of 
C2C12 myoblasts stably expressing GFP 
fusions of filamin-B variants, 6 d after 
induction of differentiation. Sarcomeric 
MHC was immunolabeled in cells to 
facilitate myotube identification (A–D). 
The pouch-like myotubes of filamin-B 
and filamin-Bvar-1 expressing cells and 
the thinner myotubes in cells expressing 
the  H1 variants are clearly detectable. 
(E) Staining of differentiated myotubes 
with anti-sarcomeric  -actinin. (F) Same 
field showing GFP fluorescence of 
filamin-B at Z- and M-lines (F). Arrow-
heads indicate Z-lines. Bars: (A–D) 100 
 m; (E and F) 10  m.372 The Journal of Cell Biology | Volume 156, Number 2, 2002
of these assays showed that the affinity of  1D for talin is
greater than that of  1A, which could result in  1D having
a stronger link with the cytoskeleton (Belkin et al., 1997;
Pfaff et al., 1998; Zent et al., 2000). In addition, the affinity
of the  7 integrin subunit for filamin appeared to be high,
whereas that of  1A and  1D was found to be intermediate
and low, respectively (Pfaff et al., 1998; Zent et al., 2000).
Our data suggest that  1 integrins hardly interact with fil-
amin-A or filamin-B and that most of their binding activity
toward these filamin isoforms is with the variant-1 forms. In
agreement with previous findings, we observed that the
binding of  1A to filamin-Avar-1 and filamin-Bvar-1 is stronger
than that of  1D. Loo et al. (1998) has previously reported
that filamin-A can interact with the cytoplasmic domain of
 1A. However, their conclusion was based on the binding
of  1A to a construct containing the COOH-terminal 478
amino acids of filamin-A. This fragment corresponds to fil-
amin-A(20*–24), whose binding properties resemble those
of filamin-Avar-1. However, a longer filamin-A protein, ex-
tending 176 amino acids at the NH2 terminus, does not
bind to integrin   subunits. Thus, the apparent discrepan-
cies between these reported data and ours might be due to
the fact that those studies were concerned with the interac-
tion of  1A with a splice variant of filamin-A rather than
with wild-type filamin-A. Similarly, the filamin proteins
previously identified in pull-down experiments using dimer-
ized integrin cytoplasmic domains presumably do not repre-
sent wild-type filamin, but filamin splice variants (Pfaff et
al., 1998; Calderwood et al., 1999).
The discrepancy between our pull-down interaction re-
sults (Fig. 3) and those of yeast two-hybrid assays (Fig. 2) on
the interaction of filamin-B variants with  1D probably can
be reduced to a difference in sensitivity between these two
assays; the yeast two-hybrid assay being more sensitive than
the pull-down assay. Indeed, we found in the  -galactosi-
dase assays that binding of  1D to filamin-Bvar-1 is weaker
than that of  1A. An alternative explanation might be that
in the GST– 1D fusion protein, the  1D cytoplasmic se-
quences are not readily accessible for binding.
Based on the immunoglobulin-like folding of several fil-
amin repeats that are present in the gelation factor of Dic-
tyostelium (Fucini et al., 1997; McCoy et al., 1999), it is
likely that as a result of the 41–amino acid deletion, three
 -strands of the two adjacent repeats 19 and 20 (strand G
from repeat 19 and strands A and B from repeat 20) were
lacking in the filamin-A and filamin-B variants. Removal of
this stretch of 41 amino acids probably led to the exposure
of one or more cryptic binding sites for integrin   subunits
in the remaining part of repeat 20 of filamin-A and filamin-B.
Alternatively, the disruption of repeat 19 may have re-
moved elements inhibiting the binding of filamin-B to  1A.
Finally, together with the deleted 41 amino acids in hu-
man filamin-Bvar-1, a conserved cAMP-kinase consensus site
(serine 2150) was removed that, when phosphorylated in fil-
amin-A, confers an increased resistance to calpain cleavage at
residues 1761–1762 in the H1 region (Gorlin et al., 1990;
Jay et al., 2000). This suggests long-range conformational
effects by the 19 and 20 repeat region of filamin and, al-
though serine 2150 is not conserved in murine filamin-B,
deletion of this region may have additional effects beyond
the modulation of the strength and specificity of filamin- –
integrin interactions. Interestingly, filamin-C contains an
insertion of 82 amino acids, exactly juxtaposed to the ho-
mologous variant-1 region, which could give specific fea-
tures to this filamin variant associated with striated muscle
(Thompson et al., 2000). Evidence of alternative splicing of
mRNA has not yet been reported for this region (Xie et al.,
1998).
Specialized cellular roles and specific cellular 
localization of filamin-B variants
Several previous reports have indicated complex expression
patterns of filamin variants during myogenesis (Gomer and
Lazarides, 1981, 1983a,b; Chiang et al., 2000). In this
study, we extended those data by the identification of ad-
ditional filamin-Bvar and H1 splice variants. We demon-
strate that removal of the H1 region from filamin-B and
filamin-C is induced during myogenesis in vitro. Further-
more, the presence or absence of the H1 region in fila-
min-B affects the morphology of the formed myotubes.
Filamin-B variants lacking H1 form thinner myotubes in
contrast to the more pouch-like tubes formed by H1-con-
taining filamins.
Deletion of the H1 region from both filamin-B and fil-
amin-C might determine the type of actin filaments with
which these filamin isoforms interact. This would explain
why during differentiation of myoblasts into myotubes, a
process that is associated with a dramatic reorganization of
the cytoskeleton, the splicing of the mRNA for this region is
regulated and why forced expression of it has such a dra-
matic effect on the morphology of the formed myotubes.
Parallel bundles of actin filaments might become more
tightly packed by the loss of the H1 region of filamin, be-
cause the flexibility of the filamin dimer lacking the H1 re-
gion is reduced, as has been anticipated by Gorlin et al.
(1990). Our observation that filamin-B variants lacking the
H1 region show the tendency to be more polarized at the
ends of actin stress fibers supports this hypothesis. The iden-
tification of shorter filamin-B( H1s) alternative splice vari-
ants in several murine and human tissues provides additional
possibilities for the modulation of the H1 region, and subse-
quent effects on the organization of the F-actin network.
Indeed, several studies have shown the effects of differ-
ences in the organization of the actin cytoskeleton on
myoblast morphology and differentiation. For example, ex-
pression of dystrophin, or its homologue utrophin, in dys-
trophin-deficient mdx mice affects the type of fibers present
in muscle (Rafael et al., 2000). Also, RhoA-mediated induc-
tion of stress fibers increases myoblast differentiation, in
contrast to the inhibitory effects on myogenesis by Rac-1
and Ras (Wei et al., 1998; Gallo et al., 1999).
By transfecting filamin-B variants into cells, it was shown
that the colocalization of filamin with  1-integrin–contain-
ing focal adhesions is not solely dependent on the presence
of an integrin-binding site on filamin-Bvar-1. Only the fil-
amin-Bvar-1( H1) variant, in which a high affinity binding
site for  1A and  1D is combined with the absence of the
H1 region, is concentrated at the tips of actin stress fibers,
where it is colocalized with  1 integrins. Two previously de-
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Bvar-1( H1) (Pavalko et al., 1989; Tachikawa et al., 1997),
because of their localization at the ends of stress fibers in fo-
cal adhesions or at the dense plaques in smooth muscle cells.
It is possible that the effect induced by the loss of the H1 re-
gion permits the linkage of filamin-Bvar-1( H1) with special
organized actin stress fibers in focal contacts, thereby facili-
tating binding of the variant-1 site to integrins. However,
there are other possible explanations, e.g., similar to the de-
letion of the var-1 region, the deletion of the H1 region may
have induced a binding site for one or more focal contact
proteins that, together with  1, mediate the localization of
filamin-Bvar-1( H1) in focal contacts.
Our finding that filamin-Bvar-1( H1) is present together
with talin in focal contacts raises the question of which of
these two proteins is actually associated with  1. Filamin-
Bvar-1( H1) and talin bind to overlapping sites on the  1 cy-
toplasmic domain and, therefore, it seems unlikely that these
two proteins simultaneously bind to  1. We believe it is rea-
sonable to assume that a proportion of  1 is associated with
talin, whereas other  1 subunits interact with filamin-Bvar-1
( H1). An alternative possibility, which we consider to be
less likely, but nevertheless cannot formally be excluded, is
that only filamin-Bvar-1( H1) is associated with  1 and talin
is retained in focal contacts by an interaction with vinculin.
Previous reports have indicated a critical role for integrins
in myogenic differentiation (Menko and Boettiger, 1987;
Sastry et al., 1996) and muscle integrity (Volk et al., 1990;
Mayer et al., 1997; Hayashi et al., 1998). Conceivably, the
acceleration of myogenesis observed in C2C12 cells express-
ing filamin-Bvar-1( H1) might be due to an altered interac-
tion of this filamin variant with the  1 integrins. An in-
creased interaction may help to stabilize the expression of
integrins at the cell surface by firmly anchoring them to the
actin cytoskeleton. For example, the reexpression of fila-
min-A, in filamin-A–deficient melanoma cells, has been as-
sociated with an increase in the surface levels of both the
GP-Ib  and  1 integrins (Meyer et al., 1998). However, we
did not detect, by FACS
® analysis, any changes in surface
expression levels of  1 integrins upon the ectopic expression
of filamin-B variants (unpublished data). This discrepancy
could be due to the complete lack of filamin-A in the M2
cells used by Meyer et al. (1998). If cells contain endogenous
filamin, the ectopic expression of filamin has no detectable
effects. The effects of filamin-Bvar-1( H1) on myogenesis
may also be the consequence of a different localization and/
or function of integrins in C2C12 cells. Indeed, as already
mentioned, the distribution of filamin-Bvar-1( H1) is typi-
cally polarized in differentiating C2C12 cells and is localized
together with  1 in focal contacts in GD25- 1A cells.
However, whatever the underlying mechanism for the effect
of filamin-Bvar-1( H1) on myogenesis is, the physiological
significance of it remains uncertain, because it could not be
demonstrated that this variant is expressed in C2C12 cells.
In conclusion, our study provides the first evidence that
alternative mRNA splicing controls the cellular localization
of filamins and their interaction with integrins. This indi-
cates that individual filamin variants could be specialized in
linking integrins or other transmembrane proteins to the
actin cytoskeleton, comparable to the filamin-C–specific
(Thompson et al., 2000) and dystrophin-mediated connec-
tion with the sarcoglycan adhesion complex in muscle cells.
Ultimately, these specific activities of filamin variants modu-
late cell morphology and differentiation.
Materials and methods
Cell lines and antibodies
CHO cells were grown in DME supplemented with 10% FCS and 1% non-
essential amino acids. Murine GD25 fibroblasts, lacking the endogenous
 1 integrin subunit, were a gift of Dr. R. Fässler (Lund University Hospital,
Lund, Sweden; Fässler et al., 1995). GD25- 1A or GD25- 1D cell lines
were generated by retroviral transduction of GD25 cells with cDNA con-
structs for human  1A or  1D, and maintained in DME supplemented with
10% FCS, as described previously (Gimond et al., 1999). The murine myo-
blast cell line C2C12 (American Type Culture Collection; accession no.
CRL 1772) was propagated in DME supplemented with 20% FCS and high
glucose (4.5 g/liter). Terminal differentiation of confluent C2C12 monolay-
ers to multinuclear myotubes was induced by changing the culture me-
dium to DME containing 2% horse serum (Yaffe and Saxel, 1977). All me-
dia were supplemented with penicillin and streptomycin. Retrovirally
transduced cells were selected with 0.2 mg/ml zeocin (Invitrogen). All cell
lines were grown at 37 C in a humidified, 5% CO2 atmosphere.
The mouse anti-vinculin (V11F9) (Glukhova et al., 1990) was provided
by Dr. M. Glukhova (Institut Curie, Paris, France). The mouse anti- 1D cy-
toplasmic domain (2B1) and rabbit anti–filamin-B (H1) antibodies have
been described previously (van der Flier et al., 1997; Takafuta et al., 1998).
Mouse anti-sarcomeric  -actinin (EA-53), anti-talin (8d4), and  -actinin
(BM-75.2) were purchased from Sigma-Aldrich; mouse anti-paxillin (349)
and anti-phosphotyrosine (PY20) were from Transduction Laboratories;
mouse anti–Gal4 binding domain (BD), mouse anti–Gal4 activation do-
main (AD), and rabbit anti-HA antibodies (sc-510, sc-1663, and sc-805,
respectively) were from Santa Cruz Biotechnology, Inc.; mouse anti-HA
(12CA5) were from Boehringer; mouse anti-sarcomeric MHC (MF20) were
from the Developmental Studies Hybridoma Bank; and rabbit and mouse
anti-GFP (B34) were from CLONTECH Laboratories, Inc. and BabCO. The
sheep anti–mouse and donkey anti–rabbit HRP-conjugated antibodies
were obtained from Amersham Pharmacia Biotech. TO-PRO-3 iodide, Al-
exa
®-568–coupled phalloidin, and Texas red–conjugated goat anti–mouse
and goat anti–rabbit were from Molecular Probes.
Yeast two-hybrid screen and plasmid constructs
The  1D (amino acids 752–798) or  1A cytoplasmic domain (amino acids
752–801) were fused to the Gal4 DNA BD in pAS2.1 (CLONTECH Labora-
tories, Inc.). These constructs were used as bait in yeast two-hybrid screens
of a human skeletal muscle and a human keratinocyte library (CLONTECH
Laboratories, Inc.; HL4010AB and HL4024AB, respectively) in the yeast
Gal4 transcriptional AD expression vector pGAD10 (CLONTECH Labora-
tories, Inc.). Plasmids were introduced into the yeast host strains PJ69–4A
(a gift from Dr. P. James, University of Wisconsin, Madison, WI; James et
al., 1996) or Y190 (CLONTECH Laboratories, Inc.) by transformation. The
yeast two-hybrid library screen was performed essentially according to the
CLONTECH Laboratory, Inc. two-hybrid manual. 
To analyze the protein–protein interactions of truncated filamin-A and
filamin-B with several integrin cytoplasmic tails, mutants, and truncated
filamins, pACT (-derived) and pAS (-derived) constructs were cotrans-
formed into the yeast strain PJ69–4A. Interaction was assayed by selection
for growth on plates containing SC-LTHA, a yeast synthetic complete me-
dium lacking the vector markers Leu and Trp, as well as the interaction
markers His and Ade, and containing 2 mM 3-aminotriazole (Sigma-Aldrich;
A8056) to suppress residual histidine synthesis in the strain PJ69–4A,
as described previously (Geerts et al., 1999). Interaction was scored as the
percentage of the plating efficiency on SC-LTHA containing 2 mM 3-ami-
notriazole compared with the plating efficiency on SC-LT, a medium lack-
ing only the vector markers Leu and Trp, when grown for 5 or 10 d at
30 C. Quantitative determination of  -galactosidase activities was per-
formed in triplicate using of three independent clones grown in SC-LT with
O-nitrophenyl B-D-galactopyranoside (Sigma-Aldrich) as the substrate, ac-
cording to the manufacturer’s recommendations.
All filamin-A and filamin-B deletion constructs (starting at the amino ac-
ids as indicated in Figs. 2 and 4; for amino acid alignment see van der Flier
and Sonnenberg, 2001a) were generated by PCR using Pwo DNA poly-
merase (Roche Molecular Biochemicals). Filamin-A and filamin-B deletion
constructs were cloned in the modified yeast expression vector, pACT2.4
(Gal-4[AD], a derivative of pACT2.1) or pAS2.1 (Gal4[BD]). The Gal4(BD)
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the pAS2.1 have been described previously (Wixler et al., 2000). The  6
cytoplasmic domain construct in pAS2.1 was a gift of S. Spong (Lung Biol-
ogy Center, University of California San Francisco, San Francisco, CA).
The  1 chimeric cytoplasmic domains  1A/D
792,  1A/D
796, and  1D/A
787
were generated by PCR and cloned into pAS2.1. All plasmid constructs
were checked by sequencing, and the expression of fusion proteins in
yeast was confirmed by immunoblotting with Gal4(BD)- and (AD)-specific
antibodies. None of the filamin constructs used activated the reporter
genes autonomously in yeast, nor did they bind to any of several different
integrin  -subunits tested.
Genomic PCR and RT-PCR analysis
RT-PCR analysis was performed on Human Multiple Tissue cDNA Panel I
and II (CLONTECH Laboratories, Inc.) using Taq DNA polymerase and
primers deduced from the human filamin-B sequence.
The following primer sets were used to detect the human filamin-Bvar-1
cDNA: either BV1/BV2 or nested PCR using primers BV9/BV11 on the
BV9/BV10 PCR products. BV11 specifically amplifies the filamin-Bvar-1
cDNA because it spans the 123-nt deleted sequence with one basepair at
its 3  end. Similarly, human filamin-Avar-1 was detected using the nested
primers AV1/AV3 on the AV1/AV2 PCR product. Human filamin-Bvar-1
( H1) transcripts with or without the H1 region were detected using prim-
ers BV12/BV13. Genomic sequences encoding repeats 19 and 20 of hu-
man filamin-B were determined by PCR using Taq DNA polymerase on
human genomic DNA isolated from two different cell lines, using a stan-
dard procedure and combinations of the primers BV1–BV8 as indicated
in Fig. 1 C. All BV primers are numbered according to the filamin-B se-
quence data available from GenBank/EMBL/DDBJ under accession no.
NM_001457, except primers BV7 and BV8, which are numbered accord-
ing to sequence data submitted under accession no. AF353666. Number-
ing of AV primers is according to the filamin-A sequence available un-
der accession no. NM_001456. BV1: GAAGATGGCACCTGCAAAGTC
(6288–6308); BV2: GACCGGCACCAGGTAGGG (6971–6954); BV3:
GTGCCTGGGGTTTATATCGTC (6324–6344); BV4: GGTGCGGGTGAT-
GCTCTCT (6437–6419); BV5: GGAGGGAAGAGTCAAAGAGAG (6404–
6424); BV6: GATCTGGGCAGAGCAGTTC (177–159); BV7: GAACT-
GCTCTGCCCAGATC (159–177); BV8: CACGGTGAACTGGAAGGGG
(6686–6668); BV9: TCCAGTCGGAGATTGGTGA (6115–6133); BV10:
GACCGGCACCAGGTAGGG (6971–6954); BV11: ATATCACTGCTGT-
TGATTTC/A (6517–6498/6374); BV12: GTGACCTGCACGGTTCTGA
(5071–5089); BV13: ATCACTGCTGTTGATTTC/AGGC (6513–6496/
6372–6369); AV1: ACCCGCGATGCAGGCTATG (6386–6404); AV2:
CACGGTGAACTGGAAGGGG (6690–6672); AV3: CCGACCAGCACGT-
GCCTG/A (6543–6771/6675).
Total RNA from C2C12 cells was isolated at various time points after
myotube induction, using RNAzol™B (Tel-Testine), as recommended by
the manufacturer. Subsequently, cDNA was prepared from 10  g RNA us-
ing an oligo d(T)15 primer and SuperScript™ (Life Technologies). The H1
regions of murine filamin-A, filamin-B, and filamin-C (partial sequences
are deposited under GenBank/EMBL/DDBJ accession nos. AF353668,
AF353669, and AF354670, respectively) were amplified using the primer
sets mAH1/mAH2, mBH1/mBH2, and mCH1/mCH2, respectively. mAH1:
CCTGATGGCTCAGAGGTAGA (1–20); mAH2: GTGATCTCCCCTTCT-
TGATA (344–324); mBH1: CTGACGTCATTGAAAATGAAGAT (1–23);
mBH2: AATGGAATCACCAAGTCAAAGG (274–253); mCH1: GATGG-
GGCAGAGCTCGATG (1–19); mCH2: GTCAGCTCCCCTTTCTGCAC
(341–322).
For the detection of potential murine filamin-A and filamin-B variant-1
mRNAs (partial sequences are deposited under GenBank/EMBL/DDBJ ac-
cession nos. AF353671 and AF353672, respectively), RT-PCR was per-
formed using mAV1/mAV2 and mBV1/mBV2, respectively. The variant-1
products were further amplified by nested PCR using the mAV1/mAV3 and
mBV1/mBV3 primer sets on 1  l of the RT-PCR products. mAV1: GGC-
TACGGTGGGCTTAGTC (1–19); mAV2: GAAGGGGCTCCCAGGTACA
(453–435); mAV3: TGACCAGCATGTGCCTG/A (138–154/278); mBV1:
AGGCTATGGTGGCATATCCT (1–20); mBV2: GAACGGGCTTCCTGT-
TACG (454–436); mBV3: GCTGACGAGCATGTGCCTG/A (137–155/278).
Murine   1A and  1D integrin (GenBank/EMBL/DDBJ accession no.
Y00769) were analyzed using GGCAACAATGAAGCTATCG (2219–2237)
and CCCTCATTCGGATTGAC (2484–2465) as a primer set. PCR products
were analyzed on 2% agarose gels and the identity of all PCR products
was confirmed by cloning and subsequent sequencing.
Cloning of HA-tagged and GFP fusion proteins
Truncated forms of filamin-A and filamin-B were fused to the NH2-terminal
HA epitope tag in pcDNA3-HANII, a modified pcDNA3 vector (Invitro-
gen). pCI-puro-eGFPc was generated by inserting an eGFP PCR product,
using pEGFP-N1 (CLONTECH Laboratories, Inc.) as a template, into pCI-
puro( XbaI/NotI), a pCI-neo–derived (Promega) vector in which the
aminoglycoside phosphotransferase gene was replaced by the gene for
puromycin-N-acetyl transferase, which induces puromycin resistance.
LZRS-eGFPc-IRES-zeo was constructed by subcloning the eGFP fragment
from pCI-puro-eGFPc into the retroviral expression vector LZRS-ms-IRES-
zeo (Kinsella and Nolan, 1996; van Leeuwen et al., 1997). The four fusion
proteins of full-length filamin-B variants and GFP as depicted in Fig. 7 A
were generated by a three point ligation into the XbaI/NotI sites of pCI-
puro-eGFPc. All four possible combinations between one 5  filamin-B
fragment (XbaI/SacII), either containing or not containing the H1 region,
and one 3  filamin-B fragment (SacII/NotI), either wild-type or variant-1,
were prepared. Retroviral expression constructs were obtained by reclon-
ing the above filamin-B variants from pCI-puro-eGFP into the retroviral
vector LZRS-eGFPc-ms-IRES-zeo. The 5  filamin-B fragment containing the
H1 region was obtained by XbaI/SacII digestion of wild-type filamin-B
(Takafuta et al., 1998). A 3  filamin-B fragment containing a 3  NotI site for
in-frame fusion with GFP was generated by PCR, using primer set D4/U5
and full-length filamin-B as template. A 5  filamin-B fragment lacking H1
(amino acids 1704–1727) was generated by fusion PCR. In brief, two PCR
products were obtained using D1/U1 and D2/U2 primer pairs. Products
were annealed through overlapping sequences (underlined) and reampli-
fied with D1/U2 to yield the H1 deletion. This PCR product was then used
to replace the MunI/SacII fragment of wild-type filamin-B. A 3  fragment of
filamin-Bvar-1, containing an intrinsic SacII and an in-frame 3  NotI site was
generated by fusion PCR. One PCR product was obtained using primer set
D4/U4 and wild-type filamin-B as template. The other PCR product was
obtained using primer set D5/U5 and filamin-Bvar-1 cDNA as template. The
final fusion PCR product was obtained after reannealling the two obtained
products and reamplification using primer set D4/U5. The primers used
are under GenBank/EMBL/DDBJ accession no. NM_001457. D1: TGC-
AATTGATGCCCGAGATGC (4751–4771); U1: ACATAGGCCTCTTCGG-
TCAC/CATGACAGTGA (5332–5313/5240–5230); D2: ACAGCCCCT-
TCACTGTCATG/GTGACCGAAGAGG (5221–5240/5313–5325); U2:
GGCCGCGGCCATAGACTTT (6165–6147); D4: GTCCAGTCGGAGAT-
TGGTGA (6114–6133); U4: CCACCGCCAAGGATATGCC (6249–6231);
D5: GGCATATCCTTGGCGGTGG (6231–6249); U5: gcggcggccgcgAG-
GCACTGTGACATGAAAAGG (7937–7917) (NotI site is in bold).
Binding to GST fusion proteins
For pull-down assays,  1A and  1D cytoplasmic domains were fused with
GST in the bacterial expression vector pRP261, a derivative of the pGEX-
3X vector. The recombinant proteins were expressed in Escherichia coli
strain BL21 (DE3) and purified from bacterial lysates by the use of glu-
tathione-Sepharose 4B beads. Constructs encoding NH2-terminally trun-
cated filamins were transfected in COS-7 cells using the DEAE-dextran
method (two 10-cm Petri dishes with 10
6 seeded cells were used for three
pull-down assays). 48 h after transfection, cells were lysed for 20 min in 1
ml ice cold lysis buffer (10 mM Pipes, pH 6.8, 50 mM NaCl, 150 mM su-
crose, 0.5% Triton X-100, 1 mM EDTA, 10  g/ml calpeptin, 1 mM PMSF,
10  g/ml soybean trypsin inhibitor, 10  g/ml leupeptin, and 0.1 U/ml
aprotinin). Lysates were cleared by centrifugation at 15,000 g for 10 min at
4 C, and subsequently diluted 10 times in dilution buffer (10 mM Pipes,
pH 6.8, 50 mM NaCl, 150 mM sucrose, 3 mM MgCl2). Diluted lysates
were incubated overnight at 4 C with 15  l glutathione-Sepharose 4B
beads containing 50  g GST fusion proteins. The beads were washed with
the same lysis buffer and centrifuged through a sucrose cushion (10 mM
Pipes, pH 6.8, 50 mM NaCl, 800 mM sucrose, 1 mM MgCl2), and proteins
were resolved by SDS-PAGE and immunoblotted with anti-HA antibody.
For GST precipitations of full-length COOH-terminally GFP-tagged fil-
amins, stable retrovirally infected C2C12 or GD25- 1A cells were lysed
and incubated with the various GST fusion proteins. Expression of the full-
length GFP-tagged filamin-B variants was increased by preincubating the
cells overnight with 5 mM sodium butyrate. GST fusion protein loading of
the beads was checked by Coomassie brilliant blue staining, and the fil-
amin fusion proteins were visualized by immunoblotting, as described pre-
viously (Geerts et al., 1999).
Chemical cross-linking of the HA- and eGFP-tagged filamin-B 
truncations and immunoblotting
CHO cells were transfected with NH2-terminal HA-tagged or COOH-ter-
minal GFP-tagged truncated constructs of full-length filamin-B (FLN-B[19–
24] 
2009–2602 or FLN-Bvar-1[19–23] 
2027–2047), using a cationic lipid-based
DNA delivery protocol (Lipofectamin; Life Technologies). After a 3-h incu-
bation, the lipofectamin reagent was replaced by fresh growth medium. 2 dIntegrin binding to filamin isoforms and variants | van der Flier et al. 375
later, transfected cells were lysed in 0.5 ml lysis buffer (20 mM Hepes,
pH 7.4, 150 mM NaCl, 1.5 mM MgCl2, 1% Nonidet P-40) for 5 min on ice
and subsequently subjected to cross-linkage for 1 h on ice by adding dif-
ferent concentrations (0, 0.25, or 1 mM) of DSP (Pierce Chemical Co.; 25
mM stock in DMSO). Alternatively, the intact cell monolayer was treated
with 1 mM of the cell-permeable cross-linker, dissolved in phosphate-buff-
ered saline, for 1 h. Subsequently, the cross-linking reaction in the cell ly-
sate was stopped by adding 25  l of 1 M Tris-HCl (pH 6.8), whereas the
intact treated cells were washed twice with PBS and lysed in 50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P-40. All cell lysates were
cleared by centrifugation at 14,000 rpm for 10 min and 1/12 portions of
the total cell lysates were separated by SDS-PAGE on 7% gels under both
nonreducing and reducing (5%  -mercaptoethanol) conditions and ana-
lyzed by immunoblotting.
Immunofluorescence and flow cytometry
Bulk populations of sorted cells expressing GFP fusion proteins were
grown on coverslips and, in one step, fixed and permeabilized in 3% para-
formaldehyde, 2% Triton X-100 in PBS for 10 min at room temperature.
Cells were blocked in PBS, 2% BSA for 1 h, and incubated with primary
antibodies (optionally in the presence of Alexa
®568-labeled phalloidin or
TO-PRO-3) in the same buffer for 1 h at room temperature. After washing
in PBS, cells were incubated in the presence of FITC- or Texas red–conju-
gated secondary antibodies for 1 h. Preparations were then washed in PBS,
mounted in Vectashield (Vector Laboratories), and analyzed with a confo-
cal Leica TCS NT microscope.
For flow cytometry and cell sorting, cultured cells were trypsinized,
washed twice in PBS, 2% FCS, and sorted on a FACStar Plus
® (Becton
Dickinson) by their level of GFP expression.
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